Eureka, you shouldn't worry about Dutchess. They are making plenty off of the shareholders. The genotyping services Ellipsis provides are growing exponentially. And will continue to do so. And yes....they may just run this thing into the ground.
Q4 revenue of $525,000, an increase of 42% over last year
-- Year-end revenues of $2.4 million, an increase of 91% over 2005
-- Q4 Genotyping revenue of $170,000, an increase of 643% over Q4 2005
-- Full-year Genotyping revenue of $770,000, an increase of 330% over
full-year 2005
-- Full-year revenue of $1.6 million for Ancestry products, an increase
73% over 2005